HOUSE COMMITTEE ON HEALTH AND HUMAN SERVICES
March 14, 2003 Hearing Room D
9:00 A.M. Tapes 51 52
MEMBERS PRESENT: Rep. Jeff Kruse, Chair
Rep. Billy Dalto, Vice-Chair
Rep. Carolyn Tomei, Vice-Chair
Rep. Gordon Anderson
Rep. Ben Westlund
MEMBER EXCUSED: Rep. Jeff Barker
Rep. Laurie Monnes Anderson
STAFF PRESENT: Sandy
Thiele-Cirka, Committee Administrator
Mara McGraw, Committee Assistant
MEASURES HEARD: HJM
4 Public Hearing and Work Session
HB 2374 Public Hearing
HB 2558 Public Hearing
HB 2642 Public Hearing
These minutes are in
compliance with Senate and House Rules.
Only text enclosed in quotation marks reports a speakers exact
words. For complete contents,
please refer to the tapes.
|
TAPE/# |
Speaker |
Comments |
|
TAPE 51, A |
||
|
005 |
Chair Kruse |
Calls meeting to order at 9:04 A.M. and announces HB
2684 will be postponed until March 17, 2003. Opens public hearing on HJM 4. |
|
HJM 4
PUBLIC HEARING |
||
|
008 |
Sandy Thiele-Cirka |
Administrator. Summarizes bill. |
|
014 |
Jim Gardner |
Pharmaceutical Manufacturers of America (PhRMA).
Addresses impact of bill on moving issue forward in Congress. |
|
026 |
Chair Kruse |
Closes public hearing on HJM 4 and opens work
session on HJM 4. |
|
HJM 4
WORK SESSION |
||
|
030 |
Rep.
Anderson |
MOTION: Moves HJM 4 be sent to the floor with a BE
ADOPTED recommendation. |
|
031 |
Rep. Anderson |
Addresses need for federal assistance. |
|
036 |
Chair Kruse |
Notes history of bill. |
|
040 |
Rep. Tomei |
Inquires if other states have passed similar
memorials. |
|
045 |
|
VOTE:
5-0-2 AYE: In a roll call vote, all members present vote AYE. EXCUSED: 2 Barker, Monnes Anderson |
|
049 |
Chair Kruse |
The motion CARRIES. REP. KRUSE will lead discussion on the
floor. |
|
056 |
Chair Kruse |
Closes work session on HJM 4 and opens public
hearing on HB 2374. |
|
HB 2374
PUBLIC HEARING |
||
|
058 |
Thiele-Cirka |
Summarizes bill and -1 amendment (EXHIBIT A). |
|
068 |
Bruce Carlson M.D. |
Pharmacists. Submits written testimony in support of
HB 2374 (EXHIBIT B). Addresses
impact on rural health providers and rural communities. Speaks to fiscal
impact. Suggests language for amendment. |
|
115 |
Rep. Anderson |
Inquires on formula. |
|
118 |
Carlson |
Reports formula involves 20 medications. |
|
121 |
Rep. Tomei |
Inquires on legend drugs. |
|
123 |
Carlson |
Defines legend drugs. |
|
128 |
Rep. Tomei |
Clarifies any drug requiring a prescription is a
legend drug. |
|
129 |
Carlson |
Concurs. |
|
137 |
Lynn Read |
Office of Medical Assistance Programs (OMAP),
Department of Human Services (DHS). Submits written testimony in support of
bill (EXHIBIT C). Notes current
options for rural health clinics to dispense drugs. Addresses issues of
administering the programs and billing the claims. Speaks to efforts in rural
health access. |
|
193 |
Rep. Westlund |
Notes efforts of workgroup on Oregon Health Plan (OHP).
|
|
213 |
Peggy Anet |
Health Insurance Association of America (HIAA).
Submits testimony in opposition to bill (EXHIBIT
D). Discusses concerns with mandatory reimbursement requirements. Reports
on current statue in regard to required analysis. Notes table on insurance
mandates (EXHIBIT D-page 4). Discusses
process and technical concerns relating to the insurance code. |
|
310 |
Tom Holt |
Oregon State Pharmacists Association. Testifies in
support of HB 2374. Notes support relates to small number of pre-packaged
drugs and appropriate dispensing technology. |
|
341 |
Rep. Anderson |
Inquires on physicians dispensing license. |
|
344 |
Holt |
Explains license is approved through board of medical
examiners. |
|
357 |
Karen Whitaker |
Director, Office of Rural Health, Oregon Health and Sciences
University (OHSU). Submits written testimony in support of bill (EXHIBIT E). Lists other supporting
parties. Notes rural areas that qualify under bill (EXHIBIT E-page 6). |
|
402 |
Ed Patterson |
Oregon Rural Health Organization. Submits written
testimony from Carlson. Notes lack of additional cost to insurers. Urges
adoption of -1 amendment. |
|
426 |
Rep. Westlund |
Inquires on result of excluding private insurance
from bill |
|
429 |
Patterson |
Concurs suggestion as an option. |
|
434 |
Chair Kruse |
Addresses passing incomplete bills Senate. Requests interested
parties meet and address concerns. Closes public hearing on HB 2374 and opens
public hearing on HB 2558. |
|
TAPE 52, A |
||
|
HB 2558
PUBLIC HEARING |
||
|
024 |
Thiele-Cirka |
Summarizes bill. |
|
034 |
Gardener |
Submits written testimony in support of HB 2558 (EXHIBIT F). Addresses preemptive
preclusion by Drug Use Review (DUR) Board of drugs used to treat new
conditions not yet assigned to the priority list. |
|
077 |
Rep. Tomei |
Inquires on history of bill. |
|
080 |
Gardner |
Defers to next witness. |
|
082 |
Don Stecher |
Representing Novartis Pharmaceuticals. Presents
history of the drug. |
|
109 |
Rep. Tomei |
Inquires if Oregon DUR Board has decided if the drug
is appropriate. |
|
111 |
Stecher |
Reports decision on drug has not been made. Reports that
Oregon is only state that does not cover drug for Medicaid patients. |
|
114 |
Rep. Tomei |
Clarifies drug status by Oregon DUR Board. |
|
121 |
Stecher |
States drug is not covered by Oregon Health Plan (OHP). |
|
124 |
Gardner |
Explains bill addresses a procedural process to
cease pre-emptive action on drugs and will not effect specific drugs. |
|
137 |
Rep. Tomei |
Inquires what precipitated decision. |
|
142 |
Stecher |
Explains other drugs under same policy. |
|
149 |
Rep. Tomei |
Inquires why policy was enacted. |
|
150 |
Gardner |
Explains condition drug treats and status on OHP
prioritization list. States the condition is now treatable. |
|
162 |
Rep. Tomei |
Explains attempt to understand DUR Board decision. |
|
173 |
Rep. Alan Bates |
House District 5. Comments on treatment and OHP
priority list. |
|
196 |
Gardner |
Explains treatment of conditions below the cut off
for OHP priority list. |
|
205 |
Paul Nielson |
Representing Pharmacia. Details other drugs with
history of similar restrictions. Requests allowing the drug to come to market
before placing Medicaid coverage restrictions. |
|
229 |
Holt |
Testifies in opposition to bill. Clarifies role of
DUR Board in relation to OMAP. Notes drugs grandfathered into policy. Urges
committee not to restrict DUR Board. |
|
287 |
Chair Kruse |
Comments on advisory nature of DUR Board. Notes
issue is matter of process. Explains committee will invite DUR Board to committee
to address questions. Closes public hearing on HB2558 and opens public
hearing on 2642. |
|
HB 2642
PUBLIC HEARING |
||
|
312 |
Thiele-Cirka |
Summarizes bill. |
|
327 |
Jim Anderson |
American College of Emergency Physicians, Oregon
Chapter. Offers history of bill. |
|
340 |
David Toovy M.D. |
Emergency Physician. Submits written testimony in support
of bill (EXHIBI G). Relates
patient stories relating to the bill. Lists corporations that have enacted
similar policy. Notes lack of opposition over last six years as basis to remove
the sunset. |
|
TAPE 51, B |
||
|
017 |
Nan Heim |
Oregon State Ambulance Association. Testifies in
support of bill. Requests amendment to include ambulance services. |
|
039 |
Shawn Baird |
Emergency Medical Technician (EMT) and President,
Oregon State Ambulance Association. Submits written testimony in support of
bill (EXHIBIT H). Explains role of
EMT in diagnosis and treatment. Requests amendment language to formally
recognize EMTs as essential service. |
|
070 |
Alan Bates, M.D. |
Physician, Bend, Oregon. Testifies in support of HB
2642. Addresses abuses and misuses of emergency care. Notes patients often do
not understand when to seek care and should not base decision on the expense. |
|
119 |
Rep. Anderson |
Inquires on instances in which payments should be
refused. |
|
123 |
Rep. Bates |
Explains claims can still be rejected if deemed
inappropriate. Explains some patients do not have access to or do not have a
primary care physician. Notes Emergency Room physician needs ability to
assess patient before deeming the case a non-emergency. |
|
150 |
Anet |
Notes concern relating to the sunset review policy.
Notes tendency of policies to expand with each review. Requests language to
clarify review process. Speaks to differences between ambulance and emergency
room services. |
|
195 |
Rep. Tomei |
Comments that the testimony does not address abuses
of rule. |
|
197 |
Anet |
Notes subjective nature of assessing severe pain and
perception of what constitutes an emergency. Addresses gray area in accessing
emergency services. Notes bill is companion to patient protection legislation
from 1997. |
|
240 |
Chair Kruse |
Closes public hearing on HB 2642 and adjourns
meeting at 10:33 A.M. |
EXHIBIT
SUMMARY
A
HB 2374, -1 amendment, staff, 1 p.
B
HB 2374, written testimony, Bruce Carlson, 1 p.
C
HB 2374, written testimony, Lynn Read, 2 pp.
D
HB 2374, written testimony, Peggy Anet, 4 pp.
E
HB 2374, written testimony, Karen Whitaker, 6 pp.
F
HB 2558, written testimony, James Gardner, 2 pp.
G
HB 2642, written testimony, David Toovy, 2 pp.
H
HB 2642, written testimony, Shawn Baird, 1 p.